Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Cash from Operations (2018 - 2025)

Historic Cash from Operations for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to -$36.2 million.

  • Verastem's Cash from Operations fell 5220.0% to -$36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$132.7 million, marking a year-over-year decrease of 3270.97%. This contributed to the annual value of -$104.8 million for FY2024, which is 2117.86% down from last year.
  • Verastem's Cash from Operations amounted to -$36.2 million in Q3 2025, which was down 5220.0% from -$32.7 million recorded in Q2 2025.
  • Verastem's Cash from Operations' 5-year high stood at -$9.9 million during Q4 2021, with a 5-year trough of -$38.7 million in Q1 2025.
  • Its 5-year average for Cash from Operations is -$21.9 million, with a median of -$19.8 million in 2021.
  • Over the last 5 years, Verastem's Cash from Operations had its largest YoY gain of 5423.21% in 2021, and its largest YoY loss of 12419.6% in 2021.
  • Over the past 5 years, Verastem's Cash from Operations (Quarter) stood at -$9.9 million in 2021, then crashed by 67.28% to -$16.6 million in 2022, then decreased by 22.09% to -$20.3 million in 2023, then dropped by 23.73% to -$25.1 million in 2024, then tumbled by 44.29% to -$36.2 million in 2025.
  • Its Cash from Operations stands at -$36.2 million for Q3 2025, versus -$32.7 million for Q2 2025 and -$38.7 million for Q1 2025.